ClinicalTrials.gov: "Chronic Kidney Disease" | updated in the last 30 days

1. Propaten Randomized Investigation on Cost-benefit and Efficacy
   Condition:   End-stage Renal Disease
   Interventions:   Device: Heparin-bonded vascular access graft;   Device: Conventional ePTFE hemodialysis graft
   Sponsors:   The University of Texas Health Science Center, Houston;   The University of Texas Health Science Center, Houston
   Not yet recruiting - verified May 2012
2. Study of FG-4592 in Subjects With Chronic Kidney Disease in China
   Condition:   Anemia in Chronic Kidney Disease
   Interventions:   Drug: FG-4592;   Drug: Placebo
   Sponsors:   FibroGen;   FibroGen
   Recruiting - verified May 2012
3. Evaluation of CLP With and Without Spironolactone in Heart Failure Patients With Chronic Kidney Disease
   Condition:   Heart Failure
   Intervention:   Drug: CLP
   Sponsors:   Sorbent Therapeutics;   Sorbent Therapeutics
   Recruiting - verified May 2012
4. ENhancing Maturation of Autogenous Arteriovenous Hemodialysis Access by Aggressive surveillaNCe With Duplex and Endovascular Treatment
   Condition:   End Stage Renal Disease
   Intervention:   Procedure: Duplex ultrasonography
   Sponsors:   Seoul National University Hospital;   Seoul National University Hospital
   Not yet recruiting - verified May 2012
5. A Safety Study of Tocilizumab to Improve Transplant Rates in Highly Sensitized Patients Awaiting Kidney Transplantation
   Condition:   End Stage Renal Disease (ESRD)
   Intervention:   Drug: Tocilizumab
   Sponsors:   Cedars-Sinai Medical Center;   Cedars-Sinai Medical Center
   Not yet recruiting - verified May 2012
6. Canakinumab in the Treatment of Gouty Arthritis Flare(s) and Prevention of New Flares in Patients With Chronic Kidney Disease
   Condition:   Acute Gouty Arthritis
   Interventions:   Drug: ACZ885;   Drug: Triamcinelone acetonide
   Sponsors:   Novartis;   Novartis Pharmaceuticals
   Not yet recruiting - verified May 2012
7. Sirolimus Use in Angioplasty for Vascular Access Extension
   Conditions:   End Stage Renal Disease;   Venous Stenosis
   Intervention:   Drug: Sirolimus
   Sponsors:   Lawson Health Research Institute;   Lawson Health Research Institute;   Pfizer
   Recruiting - verified May 2012
8. Exercise and Vascular Function in Haemodialysis Patients
   Condition:   Chronic Kidney Disease Stage 5
   Interventions:   Other: Intradialytic aerobic exercise;   Other: Progressive Muscle relaxation
   Sponsors:   Queen Margaret University;   Queen Margaret University;   British Kidney Patients Association
   Not yet recruiting - verified May 2012
9. Study of FG-4592 in Subjects With End-Stage Renal Disease Receiving Maintenance Hemodialysis in China
   Condition:   Anemia in End Stage Renal Disease
   Interventions:   Drug: FG-4592;   Drug: Epoetin Alfa
   Sponsors:   FibroGen;   FibroGen;   Ruijin Hospital;   RenJi Hospital;   Chang Zheng Hospital;   XinHua Hospital;   Peking University First Hospital;   First Affiliated Hospital, Sun Yat-Sen University;   Zhejiang University No 1. Hospital;   Peking Union Medical College Hospital;   Shenzhen People's Hospital
   Recruiting - verified May 2012
10. Proton Pump Inhibitor Use is Associated With High Risk of Pneumonia in Chronic Kidney Disease Patients
    Conditions:   Chronic Kidney Disease;   Pneumonia
    Intervention:  
    Sponsors:   Far Eastern Memorial Hospital;   Far Eastern Memorial Hospital
    Suspended - verified January 1998
11. Comparison of Outcomes Between Hemodialysis and Peritoneal Dialysis Patients in a Multi-Ethnic Asian Population
    Conditions:   Stage 5 Chronic Kidney Disease;   Hemodialysis;   Peritoneal Dialysis
    Intervention:  
    Sponsors:   National University, Singapore;   National University, Singapore
    Recruiting - verified May 2012
12. 4 Week Switch Study in Hemodialysis-dependent Subjects With Anemia Associated With Chronic Kidney Disease
    Condition:   Anaemia
    Interventions:   Drug: GSK1278863;   Drug: rhEPO
    Sponsors:   GlaxoSmithKline;   GlaxoSmithKline;   Pharmaceutical Product Development Clinical Research Organization (CRO)
    Not yet recruiting - verified May 2012
13. 4 Week Correction Study in Subjects With Anemia Associated With Chronic Kidney Disease Who Are Not Undergoing Dialysis
    Condition:   Anaemia
    Interventions:   Drug: GSK1278863;   Other: Placebo
    Sponsors:   GlaxoSmithKline;   GlaxoSmithKline;   Pharmaceutical Product Development Clinical Research Organization (CRO)
    Not yet recruiting - verified April 2012
14. Renal Denervation in Diabetic Nephropathy
    Conditions:   Diabetic Nephropathy;   Persistent Proteinuria With Type II Diabetes
    Interventions:   Procedure: Percutaneous renal denervation and TMNS;   Drug: Standardized antiproteinuric medication regimen includes an angiotensin receptor blocker , a diuretic , 25OH vitamin D3 and a statin
    Sponsors:   Assistance Publique - Hôpitaux de Paris;   Assistance Publique - Hôpitaux de Paris
    Not yet recruiting - verified March 2012
15. A Glomerular Filtration Rate (GFR) Measuring Study of RTA 402 in Chronic Kidney Disease (CKD) Patients With Type 2 Diabetes Mellitus
    Conditions:   Chronic Kidney Disease;   Type 2 Diabetes
    Intervention:   Drug: RTA 402
    Sponsors:   Kyowa Hakko Kirin Company, Limited;   Kyowa Hakko Kirin Company, Limited
    Recruiting - verified May 2012
16. Development of a New Non-radioactive Test for Measuring Glomerular Filtration Rate Using the Tetrapeptide N-acetyl-Ser-Asp-Lys-Pro-amide (AcSDKP-NH2)
    Conditions:   Healthy;   Chronic Kidney Disease
    Interventions:   Drug: AcSDKP-NH2 inuline;   Drug: AcSDKP-NH2 Cr-EDTA
    Sponsors:   Assistance Publique - Hôpitaux de Paris;   Assistance Publique - Hôpitaux de Paris
    Suspended - verified December 2011
17. Effect of Red Wine, White Wine and Beer on Contrast-Medium Induced Acute Kidney Injury
    Conditions:   Chronic Renal Failure/ Kidney Disease;   Contrast-medium Induced Acute Kidney Injury
    Interventions:   Dietary Supplement: Red wine;   Dietary Supplement: White wine;   Dietary Supplement: Beer
    Sponsors:   University of Cologne;   University of Cologne
    Recruiting - verified April 2012
18. Pharmacokinetic and Pharmacodynamic Study of Bardoxolone Methyl in Patients With Chronic Kidney Disease and Type 2 Diabetes
    Conditions:   Renal Insufficiency, Chronic;   Diabetes Mellitus, Type 2
    Intervention:   Drug: Bardoxolone Methyl
    Sponsors:   Reata Pharmaceuticals, Inc.;   Reata Pharmaceuticals, Inc.
    Recruiting - verified May 2012
19. Pilot Assessment of the Effects of Bardoxolone Methyl on Renal Perfusion, Systemic Haemodynamics and Cardiac Function in Patients With Chronic Kidney Disease and Type 2 Diabetes
    Conditions:   Renal Insufficiency, Chronic;   Diabetes Mellitus, Type 2
    Intervention:   Drug: Bardoxolone Methyl
    Sponsors:   Reata Pharmaceuticals, Inc.;   Reata Pharmaceuticals, Inc.
    Recruiting - verified May 2012
20. OxCKD1 -Empowering Healthy Lifestyle Choices in Chronic Kidney Disease
    Condition:   Chronic Kidney Disease
    Intervention:   Other: OxSalt care bundle
    Sponsors:   University of Oxford;   University of Oxford;   British Renal Society
    Not yet recruiting - verified May 2012
21. A Sleep Laboratory Study to Investigate the Safety and Efficacy of the Rotigotine Skin Patch in Subjects With Restless Legs Syndrome and End-Stage Renal Disease Requiring Hemodialysis
    Conditions:   Restless Legs Syndrome;   End-Stage Renal Disease
    Interventions:   Drug: Rotigotine;   Drug: Placebo
    Sponsors:   UCB, Inc.;   UCB, Inc.
    Recruiting - verified April 2012
22. Global SYMPLICITY Registry
    Conditions:   Hypertension;   Diabetes Mellitus;   Heart Failure;   Chronic Kidney Disease;   Sleep Apnea
    Intervention:   Device: Medtronic Renal Denervation System
    Sponsors:   Medtronic Vascular;   Medtronic Vascular
    Recruiting - verified April 2012
23. Assessing Perceived Versus Actual Knowledge and Quality of Life in Pre-Dialysis Chronic Kidney Disease (CKD) Patients
    Conditions:   Chronic Kidney Disease Stage 3;   Chronic Kidney Disease Stage 4;   Chronic Kidney Disease Stage 5
    Intervention:  
    Sponsors:   National University, Singapore;   National University, Singapore
    Recruiting - verified April 2012
24. Impact of a Multidisciplinary Intensive Management Clinic on Outcomes in Multi-Ethnic Asian Incident Hemodialysis Patients
    Condition:   Stage 5 Chronic Kidney Disease
    Intervention:   Other: Multidisciplinary, intensive and collaborative care
    Sponsors:   National University, Singapore;   National University, Singapore
    Recruiting - verified April 2012
25. A Prospective Open-Label Pilot Clinical Study Evaluating the Efficacy of Paricalcitol On Erythropoietin Consumption in Calcitriol-Resistant Patients
    Conditions:   Stage 5 Chronic Kidney Diseases;   Moderate to Severe Secondary Hyperparathyroidism
    Intervention:   Drug: Paricalcitol
    Sponsors:   Abbott;   Abbott
    Not yet recruiting - verified April 2012
26. A Phase 3 Study Comparing the Effects of Intravenous Epoetin Hospira and Epoetin Alfa (Amgen) in Patients With Chronic Renal Failure Requiring Hemodialysis and Receiving Epoetin Maintenance Treatment
    Conditions:   Chronic Kidney Disease;   Chronic Renal Failure
    Interventions:   Biological: Epoetin Hospira;   Biological: Epogen (Amgen)
    Sponsors:   Hospira, Inc.;   Hospira, Inc.
    Recruiting - verified May 2012
27. A Phase 3 Study Comparing the Effects of Subcutaneous Epoetin Hospira and Epoetin Alfa (Amgen) in Patients With Chronic Renal Failure Requiring Hemodialysis and Receiving Epoetin Maintenance Treatment
    Conditions:   Chronic Renal Failure;   Chronic Kidney Disease
    Interventions:   Biological: Epoetin Hospira;   Biological: Epogen Amgen
    Sponsors:   Hospira, Inc.;   Hospira, Inc.
    Recruiting - verified May 2012
28. Observational Study of Kibow Biotics in Chronic Kidney Failure Patients on Dialysis
    Condition:   Chronic Kidney Disease
    Intervention:   Dietary Supplement: Kibow Biotics
    Sponsors:   Kibow Biotech Inc.;   Kibow Biotech Inc.;   State University of New York - Downstate Medical Center
    Recruiting - verified May 2012
29. Observational Study of Kibow Biotics in Dialysis Patients
    Condition:   Chronic Kidney Failure
    Intervention:   Dietary Supplement: Kibow Biotics
    Sponsors:   Kibow Biotech Inc.;   Kibow Biotech Inc.;   Thomas Jefferson University
    Recruiting - verified May 2012
30. Observational Study of Kibow Biotics in Chronic Kidney Failure Patients
    Condition:   Chronic Kidney Failure
    Intervention:   Dietary Supplement: Kibow Biotics/Renadyl
    Sponsors:   Kibow Biotech Inc.;   Kibow Biotech Inc.;   Thomas Jefferson University
    Recruiting - verified May 2012
31. Pharmacokinetics Following Single-dose of Valsartan in Japanese Pediatric Patients
    Conditions:   Hypertension;   Chronic Kidney Disease;   Nephrotic Syndrome
    Intervention:   Drug: Valsartan (VAL489)
    Sponsors:   Novartis;   Novartis Pharmaceuticals
    Completed - verified May 2012
32. A Study of LY2623091 in Male and Females With Chronic Kidney Disease
    Condition:   Chronic Kidney Disease
    Interventions:   Drug: LY2623091;   Drug: Eplerenone
    Sponsors:   Eli Lilly and Company;   Eli Lilly and Company
    Recruiting - verified April 2012
33. Risk Factors for Coronary Artery Calcification and Left Ventricular Hypertrophy in Hemodialysis Patients
    Condition:   End Stage Renal Disease
    Intervention:  
    Sponsors:   University of Alberta;   University of Alberta;   Massachusetts General Hospital
    Recruiting - verified May 2012
34. Reducing Residual Albuminuria in Subjects With Diabetes and Nephropathy With Atrasentan
    Conditions:   Diabetic Nephropathy;   Chronic Kidney Disease
    Interventions:   Drug: Atrasentan low dose group;   Drug: Atrasentan high dose group;   Drug: Atrasentan placebo group
    Sponsors:   Abbott;   Abbott
    Active, not recruiting - verified April 2012
35. A Study of MK-3102 in Participants With Impaired Renal Function (MK-3102-009)
    Conditions:   Chronic Renal Insufficiency;   Type 2 Diabetes Mellitus
    Intervention:   Drug: MK-3102
    Sponsors:   Merck;   Merck
    Completed - verified April 2012
36. Safety and Effects of Supplementation With Ergocalciferol on Erythropoietin Dosing in Hemodialysis Patients
    Condition:   End Stage Renal Disease
    Interventions:   Dietary Supplement: ergocalciferol supplementation;   Other: placebo
    Sponsors:   Dialysis Clinic, Inc.;   Dialysis Clinic, Inc.
    Recruiting - verified April 2012
37. Study of Elotuzumab in Combination With Lenalidomide and Dexamethasone in Subjects With Multiple Myeloma and Various Levels of Renal Function
    Condition:   Multiple Myeloma
    Interventions:   Drug: Lenalidomide;   Drug: Dexamethasone;   Drug: Dexamethasone;   Drug: Dexamethasone;   Biological: Elotuzumab (BMS-901608; HuLuc63);   Drug: Lenalidomide;   Drug: Lenalidomide
    Sponsors:   Bristol-Myers Squibb;   Bristol-Myers Squibb;   Abbott Biotherapeutics Corp.
    Recruiting - verified October 2011
38. A Study to Evaluate the Safety of Paricalcitol Capsules in Pediatric Subjects Ages 10 to 16 With Stage 5 Chronic Kidney Disease Receiving Peritoneal Dialysis
    Conditions:   Secondary Hyperparathyroidism;   End-Stage Renal Disease
    Intervention:   Drug: Paricalcitol
    Sponsors:   Abbott;   Abbott
    Recruiting - verified May 2012
39. Quality of Life in Greek Hemodialysis Patients Receiving Zemplar Intravenous
    Conditions:   Chronic Kidney Disease;   Secondary Hyperparathyroidism
    Intervention:  
    Sponsors:   Abbott;   Abbott
    Recruiting - verified May 2012
40. Endotoxin, Neutrophil Function and Albumin in Renal Insufficiency
    Conditions:   Chronic Renal Insufficiency;   Acute Renal Failure
    Intervention:  
    Sponsors:   Medical University of Graz;   Vanessa Stadlbauer-Koellner, MD;   Austrian Science Foundation
    Recruiting - verified April 2012
41. Safety and Tolerability of Valsartan in Children 6 to 17 Years of Age
    Conditions:   Hypertension;   Chronic Kidney Disease
    Intervention:   Drug: Valsartan
    Sponsors:   Novartis;   Novartis
    Recruiting - verified May 2012
42. Safety and Efficacy of the Addition of Alanyl-Glutamine-Dipeptide to Dialysis Solution in Peritoneal Dialysis
    Condition:   End Stage Renal Disease
    Intervention:   Drug: Dipeptiven (Alanyl-glutamine-dipeptide)
    Sponsors:   Medical University of Vienna;   Christoph Aufricht
    Recruiting - verified April 2012
43. BAY94-8862 Dose Finding Trial in Subjects With Chronic Heart Failure and Mild (Part A) or Moderate (Part B) Chronic Kidney Disease
    Condition:   Heart Failure
    Interventions:   Drug: BAY94-8862;   Drug: BAY94-8862;   Drug: BAY94-8862;   Drug: BAY94-8862;   Drug: Placebo;   Drug: Spironolactone
    Sponsors:   Bayer;   Bayer
    Active, not recruiting - verified May 2012
44. Post-marketing Surveillance for Hypertensive Patients With Diabetes and/or Chronic Kidney Disease
    Condition:   Hypertension
    Intervention:   Drug: Nifedipine (Adalat CR, BAYA1040)
    Sponsors:   Bayer;   Bayer
    Recruiting - verified May 2012
45. Comparison of Efficacy and Safety of Paricalcitol Injection With Maxacalcitol Injection in Adult Japanese Chronic Kidney Disease Subjects Receiving Hemodialysis With Secondary Hyperparathyroidism
    Conditions:   Secondary Hyperparathyroidism;   Hemodialysis
    Interventions:   Drug: paricalcitol;   Drug: maxacalcitol
    Sponsors:   Abbott;   Abbott;   Abbott Japan Co.,Ltd
    Completed - verified April 2012
46. A Study of PRT-201 Administered Immediately After Arteriovenous Fistula Creation in Patients With Chronic Kidney Disease
    Condition:   Chronic Kidney Disease
    Interventions:   Drug: PRT-201;   Drug: Placebo;   Drug: PRT-201
    Sponsors:   Proteon Therapeutics;   Proteon Therapeutics
    Active, not recruiting - verified April 2012
47. Pediatric Chronic Kidney Disease Safety and Efficacy
    Conditions:   Chronic Kidney Disease;   Hyperparathyroidism;   Hyperparathyroidism, Secondary;   Kidney Disease;   Secondary Hyperparathyroidism
    Interventions:   Drug: cinacalcet capsule;   Drug: placebo capsule;   Drug: cinacalcet tablet;   Drug: placebo tablet
    Sponsors:   Amgen;   Amgen
    Recruiting - verified May 2012
48. Bardoxolone Methyl Evaluation in Patients With Chronic Kidney Disease and Type 2 Diabetes
    Conditions:   Renal Insufficiency, Chronic;   Diabetes Mellitus, Type 2
    Interventions:   Drug: Placebo;   Drug: Bardoxolone Methyl: 20 mg
    Sponsors:   Reata Pharmaceuticals, Inc.;   Reata Pharmaceuticals, Inc.
    Recruiting - verified May 2012
49. Long-term Study in Chronic Kidney Disease (Extension From Study 14817)
    Condition:   Hyperphosphatemia
    Intervention:   Drug: Fosrenol (Lanthanum Carbonate, BAY77-1931)
    Sponsors:   Bayer;   Bayer;   Shire plc.
    Recruiting - verified May 2012
50. Growth Hormone Secretagogue MK-0677's Effect on Lean Body Mass in Chronic Kidney Disease Stage 4/5 Subjects
    Conditions:   Chronic Kidney Disease;   Kidney Disease
    Interventions:   Drug: MK-0677;   Drug: Placebo
    Sponsors:   University of Virginia;   University of Virginia;   National Institutes of Health (NIH);   Merck
    Withdrawn - verified April 2012
51. A Study in Patients With Diabetic Kidney Disease
    Conditions:   Diabetic Kidney Disease;   Diabetic Nephropathy;   Diabetic Glomerulosclerosis
    Interventions:   Drug: LY2382770;   Drug: Placebo
    Sponsors:   Eli Lilly and Company;   Eli Lilly and Company
    Recruiting - verified May 2012
52. Pilot Study of Velcade® in IgA Nephropathy
    Conditions:   Chronic Kidney Disease;   IgA Nephropathy
    Intervention:   Drug: Bortezomib (Velcade®)
    Sponsors:   The Rogosin Institute;   The Rogosin Institute;   Weill Medical College of Cornell University
    Recruiting - verified April 2012
53. Vitamin D Insufficiency and Deficiency in Chronic Kidney Disease (CKD) Patients in Singapore
    Conditions:   Stage 2-5 Chronic Kidney Disease;   Predialysis
    Intervention:  
    Sponsors:   National University, Singapore;   National University, Singapore;   National Kidney Foundation, Singapore
    Recruiting - verified May 2012
54. Iron Isomaltoside 1000 (Monofer®) in Non-Dialysis Dependent Chronic Kidney Disease and With Renal-Related Anaemia
    Conditions:   Iron Deficiency Anemia;   Chronic Kidney Disease
    Interventions:   Drug: Monofer;   Drug: Iron Sulphate
    Sponsors:   Pharmacosmos A/S;   Pharmacosmos A/S;   Max Neeman International
    Recruiting - verified June 2011
55. Safety and Efficacy of Paricalcitol Capsules in Decreasing Serum Parathyroid Hormone Levels in Children 10-16 With Chronic Kidney Disease (CKD).
    Condition:   Chronic Kidney Disease Stage 3 and 4
    Interventions:   Drug: Zemplar (paricalcitol) Capsules;   Drug: Placebo capsules
    Sponsors:   Abbott;   Abbott
    Recruiting - verified May 2012
56. Efficacy and Safety of Everolimus+EC-MPS After Early CNI Elimination vs EC-MPS +Tacrolimus in Renal Transplant Recipients
    Condition:   Chronic Renal Failure
    Interventions:   Drug: Everolimus;   Drug: Prograf
    Sponsors:   Novartis;   Novartis
    Recruiting - verified May 2012
57. Chronic Kidney Disease Antidepressant Sertraline Trial
    Conditions:   Chronic Kidney Disease;   Depression
    Interventions:   Drug: Sertraline;   Drug: placebo
    Sponsors:   Department of Veterans Affairs;   Department of Veterans Affairs;   University of Texas Southwestern Medical Center
    Recruiting - verified May 2012
58. Treatment for Periodontal Disease in Dialysis Patients
    Condition:   Periodontal Disease
    Intervention:   Procedure: Periodontal Scaling and Root Planing
    Sponsors:   University of North Carolina, Chapel Hill;   University of North Carolina, Chapel Hill;   OraPharma
    Completed - verified May 2012
59. A Study of the Safety and Tolerance of Regadenoson in Subjects With Renal Impairment
    Conditions:   Kidney Diseases;   Coronary Artery Disease
    Interventions:   Drug: Regadenoson;   Drug: Placebo
    Sponsors:   Astellas Pharma Inc;   Astellas Pharma Inc
    Completed - verified May 2012
60. Combined Bone Marrow Transplantation (BMT) and Renal Transplant for Multiple Myeloma (MM) With End Stage Renal Disease (ESRD)
    Conditions:   Multiple Myeloma;   End Stage Renal Disease
    Interventions:   Drug: Cyclophosphamide, anti-thymocyte globulin, cyclosporine;   Procedure: Kidney transplant;   Radiation: Thymic irradiation;   Procedure: Bone marrow transplant from a related donor
    Sponsors:   Massachusetts General Hospital;   Massachusetts General Hospital
    Recruiting - verified April 2012
61. Oral Paricalcitol in Stage 3 - 5 Chronic Kidney Disease
    Condition:   Chronic Kidney Disease
    Intervention:   Drug: paricalcitol
    Sponsors:   The University of Hong Kong;   The University of Hong Kong;   Abbott
    Completed - verified May 2012
62. Study of Dietary Phosphate and Mineral Homeostasis in Early Chronic Kidney Disease
    Condition:   Kidney Diseases
    Interventions:   Behavioral: High/ Low Phosphate diet;   Behavioral: High/ Low Phosphate diet;   Behavioral: High/ Low Phosphate diet
    Sponsors:   University of British Columbia;   University of British Columbia
    Recruiting - verified April 2012
63. Peritoneal Dialysis Versus Haemodialysis
    Condition:   Hemodialysis
    Interventions:   Procedure: Peritoneal dialysis;   Procedure: Haemodialysis
    Sponsors:   University Hospital, Ghent;   University Hospital, Ghent
    Recruiting - verified May 2012
64. Parathyroidectomy in Endstage Renal Disease
    Condition:   Endstage Renal Disease
    Intervention:   Procedure: parathyroidectomy
    Sponsors:   The University of Hong Kong;   The University of Hong Kong
    Completed - verified May 2012
65. Testosterone Replacement Therapy in Advanced Chronic Kidney Disease
    Conditions:   Kidney Failure;   Kidney Diseases
    Intervention:   Drug: Testim (1% testosterone gel)
    Sponsors:   Stanford University;   Stanford University
    Completed - verified May 2012
66. Protein Intake, Nutrition and Cardiovascular Diseases in Stage V CKD
    Conditions:   Hemodialysis;   End Stage Renal Disease
    Intervention:  
    Sponsors:   University of Utah;   University of Utah;   National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK);   Vanderbilt University
    Recruiting - verified May 2012
67. Study to Assess Darbepoetin Alfa Dosing for the Correction of Anemia in Pediatric Subjects With Chronic Kidney Disease
    Conditions:   Anemia;   Chronic Kidney Disease;   Kidney Disease
    Interventions:   Drug: darbepoetin alfa QW;   Drug: darbepoetin alfa Q2W
    Sponsors:   Amgen;   Amgen
    Recruiting - verified May 2012
68. Hydroxyurea and Erythropoietin to Treat Sickle Cell Anemia
    Conditions:   Sickle Cell Disease;   Chronic Kidney Disease;   Pulmonary Hypertension
    Intervention:   Drug: Erythropoietin and Hydroxyurea
    Sponsors:   National Institutes of Health Clinical Center (CC);   National Heart, Lung, and Blood Institute (NHLBI)
    Completed - verified April 2012
69. Belatacept Evaluation of Nephroprotection and Efficacy as First-line Immunosuppression (BENEFIT)
    Conditions:   Kidney Transplantation;   Chronic Kidney Failure
    Interventions:   Drug: CsA;   Drug: Belatacept LI;   Drug: Belatacept MI
    Sponsors:   Bristol-Myers Squibb;   Bristol-Myers Squibb
    Active, not recruiting - verified December 2011